nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—PTGS1—malignant glioma	0.596	0.636	CbGaD
Magnesium salicylate—PTGS2—malignant glioma	0.341	0.364	CbGaD
Magnesium salicylate—Olsalazine—IFNG—malignant glioma	0.00165	0.162	CrCbGaD
Magnesium salicylate—Trisalicylate-choline—PTGS1—malignant glioma	0.00138	0.136	CrCbGaD
Magnesium salicylate—Burning sensation—Carmustine—malignant glioma	0.00115	0.0621	CcSEcCtD
Magnesium salicylate—Stupor—Carmustine—malignant glioma	0.00107	0.0578	CcSEcCtD
Magnesium salicylate—Salicylate-sodium—PTGS1—malignant glioma	0.000838	0.0824	CrCbGaD
Magnesium salicylate—Hearing impaired—Temozolomide—malignant glioma	0.000811	0.0438	CcSEcCtD
Magnesium salicylate—Trisalicylate-choline—PTGS2—malignant glioma	0.00079	0.0777	CrCbGaD
Magnesium salicylate—Olsalazine—PPARG—malignant glioma	0.000777	0.0764	CrCbGaD
Magnesium salicylate—Depressed level of consciousness—Carmustine—malignant glioma	0.000771	0.0416	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Carmustine—malignant glioma	0.000763	0.0412	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Temozolomide—malignant glioma	0.000745	0.0402	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Temozolomide—malignant glioma	0.000737	0.0398	CcSEcCtD
Magnesium salicylate—Deafness—Temozolomide—malignant glioma	0.000626	0.0338	CcSEcCtD
Magnesium salicylate—Nepafenac—PTGS1—malignant glioma	0.000587	0.0577	CrCbGaD
Magnesium salicylate—Olsalazine—PTGS1—malignant glioma	0.000574	0.0564	CrCbGaD
Magnesium salicylate—Salsalate—PTGS1—malignant glioma	0.000488	0.048	CrCbGaD
Magnesium salicylate—Salicylate-sodium—PTGS2—malignant glioma	0.000479	0.0471	CrCbGaD
Magnesium salicylate—Ketoprofen—CXCL8—malignant glioma	0.000467	0.0459	CrCbGaD
Magnesium salicylate—Weight increased—Temozolomide—malignant glioma	0.000441	0.0238	CcSEcCtD
Magnesium salicylate—Hallucination—Carmustine—malignant glioma	0.000399	0.0216	CcSEcCtD
Magnesium salicylate—Hepatitis—Temozolomide—malignant glioma	0.000388	0.0209	CcSEcCtD
Magnesium salicylate—Hallucination—Temozolomide—malignant glioma	0.000386	0.0208	CcSEcCtD
Magnesium salicylate—Flushing—Carmustine—malignant glioma	0.000372	0.0201	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Temozolomide—malignant glioma	0.000367	0.0198	CcSEcCtD
Magnesium salicylate—Tinnitus—Temozolomide—malignant glioma	0.000361	0.0195	CcSEcCtD
Magnesium salicylate—Flushing—Temozolomide—malignant glioma	0.00036	0.0194	CcSEcCtD
Magnesium salicylate—Carbamazepine—CYP2B6—malignant glioma	0.000351	0.0345	CrCbGaD
Magnesium salicylate—Erythema—Carmustine—malignant glioma	0.000349	0.0189	CcSEcCtD
Magnesium salicylate—Erythema—Temozolomide—malignant glioma	0.000337	0.0182	CcSEcCtD
Magnesium salicylate—Nepafenac—PTGS2—malignant glioma	0.000336	0.033	CrCbGaD
Magnesium salicylate—Dysgeusia—Temozolomide—malignant glioma	0.00033	0.0178	CcSEcCtD
Magnesium salicylate—Olsalazine—PTGS2—malignant glioma	0.000328	0.0323	CrCbGaD
Magnesium salicylate—Salicylic acid—PTGS1—malignant glioma	0.0003	0.0295	CrCbGaD
Magnesium salicylate—Confusional state—Carmustine—malignant glioma	0.000287	0.0155	CcSEcCtD
Magnesium salicylate—Oedema—Carmustine—malignant glioma	0.000285	0.0154	CcSEcCtD
Magnesium salicylate—Salsalate—PTGS2—malignant glioma	0.000279	0.0274	CrCbGaD
Magnesium salicylate—Confusional state—Temozolomide—malignant glioma	0.000278	0.015	CcSEcCtD
Magnesium salicylate—Oedema—Temozolomide—malignant glioma	0.000275	0.0149	CcSEcCtD
Magnesium salicylate—Anorexia—Carmustine—malignant glioma	0.000272	0.0147	CcSEcCtD
Magnesium salicylate—Hypotension—Carmustine—malignant glioma	0.000266	0.0144	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Temozolomide—malignant glioma	0.000266	0.0144	CcSEcCtD
Magnesium salicylate—Anorexia—Temozolomide—malignant glioma	0.000263	0.0142	CcSEcCtD
Magnesium salicylate—Somnolence—Carmustine—malignant glioma	0.000253	0.0137	CcSEcCtD
Magnesium salicylate—Decreased appetite—Carmustine—malignant glioma	0.000248	0.0134	CcSEcCtD
Magnesium salicylate—Somnolence—Temozolomide—malignant glioma	0.000245	0.0132	CcSEcCtD
Magnesium salicylate—Constipation—Carmustine—malignant glioma	0.000244	0.0132	CcSEcCtD
Magnesium salicylate—Pain—Carmustine—malignant glioma	0.000244	0.0132	CcSEcCtD
Magnesium salicylate—Dyspepsia—Temozolomide—malignant glioma	0.000242	0.0131	CcSEcCtD
Magnesium salicylate—Decreased appetite—Temozolomide—malignant glioma	0.000239	0.0129	CcSEcCtD
Magnesium salicylate—Ketoprofen—PTGS1—malignant glioma	0.000238	0.0234	CrCbGaD
Magnesium salicylate—Pain—Temozolomide—malignant glioma	0.000236	0.0127	CcSEcCtD
Magnesium salicylate—Constipation—Temozolomide—malignant glioma	0.000236	0.0127	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Carmustine—malignant glioma	0.000235	0.0127	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Temozolomide—malignant glioma	0.000227	0.0123	CcSEcCtD
Magnesium salicylate—Urticaria—Temozolomide—malignant glioma	0.000219	0.0118	CcSEcCtD
Magnesium salicylate—Diarrhoea—Carmustine—malignant glioma	0.000195	0.0105	CcSEcCtD
Magnesium salicylate—Pruritus—Temozolomide—malignant glioma	0.000195	0.0105	CcSEcCtD
Magnesium salicylate—Dizziness—Carmustine—malignant glioma	0.000188	0.0102	CcSEcCtD
Magnesium salicylate—Diarrhoea—Temozolomide—malignant glioma	0.000188	0.0102	CcSEcCtD
Magnesium salicylate—Dizziness—Temozolomide—malignant glioma	0.000182	0.00983	CcSEcCtD
Magnesium salicylate—Vomiting—Carmustine—malignant glioma	0.000181	0.00978	CcSEcCtD
Magnesium salicylate—Rash—Carmustine—malignant glioma	0.00018	0.0097	CcSEcCtD
Magnesium salicylate—Dermatitis—Carmustine—malignant glioma	0.00018	0.00969	CcSEcCtD
Magnesium salicylate—Headache—Carmustine—malignant glioma	0.000179	0.00964	CcSEcCtD
Magnesium salicylate—Vomiting—Temozolomide—malignant glioma	0.000175	0.00946	CcSEcCtD
Magnesium salicylate—Rash—Temozolomide—malignant glioma	0.000174	0.00938	CcSEcCtD
Magnesium salicylate—Dermatitis—Temozolomide—malignant glioma	0.000173	0.00937	CcSEcCtD
Magnesium salicylate—Headache—Temozolomide—malignant glioma	0.000173	0.00932	CcSEcCtD
Magnesium salicylate—Salicylic acid—PTGS2—malignant glioma	0.000172	0.0169	CrCbGaD
Magnesium salicylate—Nausea—Carmustine—malignant glioma	0.000169	0.00914	CcSEcCtD
Magnesium salicylate—Nausea—Temozolomide—malignant glioma	0.000164	0.00883	CcSEcCtD
Magnesium salicylate—Ketoprofen—PTGS2—malignant glioma	0.000136	0.0134	CrCbGaD
Magnesium salicylate—ALB—Hemostasis—ATP1B2—malignant glioma	8.32e-05	0.00242	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—IFNG—malignant glioma	8.29e-05	0.00241	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—FTH1—malignant glioma	8.24e-05	0.0024	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.17e-05	0.00238	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	8.07e-05	0.00235	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	8e-05	0.00233	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.91e-05	0.0023	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—IL1B—malignant glioma	7.53e-05	0.00219	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—IL2—malignant glioma	7.51e-05	0.00218	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—IL1B—malignant glioma	7.4e-05	0.00215	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—RTEL1—malignant glioma	7.35e-05	0.00214	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	7.27e-05	0.00211	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ATP1B2—malignant glioma	7.2e-05	0.0021	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—APOD—malignant glioma	7.01e-05	0.00204	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—TNF—malignant glioma	6.76e-05	0.00197	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—TNF—malignant glioma	6.72e-05	0.00196	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—IFNG—malignant glioma	6.71e-05	0.00195	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—COX8A—malignant glioma	6.57e-05	0.00191	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IFNG—malignant glioma	6.56e-05	0.00191	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—KNG1—malignant glioma	6.56e-05	0.00191	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	6.49e-05	0.00189	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.49e-05	0.00189	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	6.48e-05	0.00189	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—PTGS2—malignant glioma	6.43e-05	0.00187	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.28e-05	0.00183	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	6.17e-05	0.00179	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ANGPT2—malignant glioma	6.13e-05	0.00178	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	6.1e-05	0.00177	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—SOD1—malignant glioma	6.09e-05	0.00177	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—IL1B—malignant glioma	5.99e-05	0.00174	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	5.98e-05	0.00174	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	5.85e-05	0.0017	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	5.84e-05	0.0017	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL2—malignant glioma	5.83e-05	0.0017	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	5.82e-05	0.00169	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	5.63e-05	0.00164	CbGpPWpGaD
Magnesium salicylate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	5.63e-05	0.00164	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PTK2—malignant glioma	5.59e-05	0.00163	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ASMT—malignant glioma	5.59e-05	0.00163	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	5.57e-05	0.00162	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	5.53e-05	0.00161	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	5.52e-05	0.0016	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—VEGFA—malignant glioma	5.47e-05	0.00159	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TNF—malignant glioma	5.47e-05	0.00159	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.46e-05	0.00159	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	5.37e-05	0.00156	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—HIST1H3B—malignant glioma	5.31e-05	0.00154	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MYB—malignant glioma	5.26e-05	0.00153	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—BCAN—malignant glioma	5.25e-05	0.00153	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.25e-05	0.00153	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—COX8A—malignant glioma	5.21e-05	0.00152	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	5.21e-05	0.00152	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.08e-05	0.00148	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—BCAN—malignant glioma	4.98e-05	0.00145	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TP53—malignant glioma	4.82e-05	0.0014	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	4.74e-05	0.00138	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	4.7e-05	0.00137	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.66e-05	0.00136	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MYC—malignant glioma	4.56e-05	0.00133	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	4.5e-05	0.00131	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—DTX1—malignant glioma	4.5e-05	0.00131	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	4.46e-05	0.0013	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	4.44e-05	0.00129	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ASMT—malignant glioma	4.43e-05	0.00129	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	4.42e-05	0.00129	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	4.37e-05	0.00127	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—TNF—malignant glioma	4.34e-05	0.00126	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.33e-05	0.00126	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TNF—malignant glioma	4.25e-05	0.00124	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	4.24e-05	0.00123	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	4.24e-05	0.00123	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—IDH2—malignant glioma	4.23e-05	0.00123	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—COX8A—malignant glioma	4.22e-05	0.00123	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—BCAN—malignant glioma	4.17e-05	0.00121	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—H3F3A—malignant glioma	4.1e-05	0.00119	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	4.06e-05	0.00118	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	4.01e-05	0.00117	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.99e-05	0.00116	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP2B6—malignant glioma	3.98e-05	0.00116	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	3.97e-05	0.00116	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.77e-05	0.0011	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TP53—malignant glioma	3.74e-05	0.00109	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3.73e-05	0.00109	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	3.71e-05	0.00108	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—IDH1—malignant glioma	3.64e-05	0.00106	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ASMT—malignant glioma	3.59e-05	0.00104	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	3.59e-05	0.00104	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	3.57e-05	0.00104	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HEY2—malignant glioma	3.53e-05	0.00103	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SPHK1—malignant glioma	3.52e-05	0.00102	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.51e-05	0.00102	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP2C18—malignant glioma	3.45e-05	0.001	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IDH1—malignant glioma	3.45e-05	0.001	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—KNG1—malignant glioma	3.38e-05	0.000983	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—BCAN—malignant glioma	3.37e-05	0.000981	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	3.37e-05	0.00098	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—IDH2—malignant glioma	3.36e-05	0.000978	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IFNA2—malignant glioma	3.31e-05	0.000964	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.29e-05	0.000958	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HEY1—malignant glioma	3.27e-05	0.000952	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.25e-05	0.000947	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	3.18e-05	0.000926	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HIST1H3B—malignant glioma	3.18e-05	0.000925	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.17e-05	0.000922	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP2B6—malignant glioma	3.16e-05	0.000919	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SOD1—malignant glioma	3.14e-05	0.000913	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.13e-05	0.000912	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	3.11e-05	0.000904	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.1e-05	0.000902	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.03e-05	0.000882	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.96e-05	0.000862	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—JAG2—malignant glioma	2.9e-05	0.000844	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—IDH1—malignant glioma	2.89e-05	0.000841	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.89e-05	0.00084	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PTK2—malignant glioma	2.88e-05	0.000839	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.86e-05	0.000833	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.86e-05	0.000832	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	2.85e-05	0.000831	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SPHK1—malignant glioma	2.8e-05	0.000813	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTT1—malignant glioma	2.79e-05	0.000812	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP2C18—malignant glioma	2.74e-05	0.000797	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—IDH2—malignant glioma	2.72e-05	0.000791	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.63e-05	0.000766	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.61e-05	0.000758	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.58e-05	0.000752	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.56e-05	0.000746	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP2B6—malignant glioma	2.56e-05	0.000744	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.55e-05	0.000741	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—H3F3A—malignant glioma	2.45e-05	0.000714	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—BCHE—malignant glioma	2.43e-05	0.000707	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	2.43e-05	0.000706	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PDGFB—malignant glioma	2.42e-05	0.000705	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SLC5A5—malignant glioma	2.4e-05	0.000699	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.35e-05	0.000685	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—IDH1—malignant glioma	2.34e-05	0.00068	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—JAG1—malignant glioma	2.31e-05	0.000673	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CAV1—malignant glioma	2.3e-05	0.000668	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.27e-05	0.000661	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.27e-05	0.000661	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FBXW7—malignant glioma	2.27e-05	0.00066	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SPHK1—malignant glioma	2.26e-05	0.000658	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.25e-05	0.000655	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP2C18—malignant glioma	2.22e-05	0.000645	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTT1—malignant glioma	2.22e-05	0.000645	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—FN1—malignant glioma	2.18e-05	0.000636	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—F2—malignant glioma	2.18e-05	0.000636	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.15e-05	0.000626	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CG—malignant glioma	2.09e-05	0.000608	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.09e-05	0.000608	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PTGS1—malignant glioma	2.08e-05	0.000604	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.07e-05	0.000602	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—EGF—malignant glioma	2.07e-05	0.000601	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PTPN11—malignant glioma	2.05e-05	0.000598	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.96e-05	0.000571	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTP1—malignant glioma	1.93e-05	0.000563	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—BCHE—malignant glioma	1.93e-05	0.000562	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—AKT2—malignant glioma	1.91e-05	0.000557	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLC5A5—malignant glioma	1.91e-05	0.000555	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.9e-05	0.000554	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.89e-05	0.000551	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CAT—malignant glioma	1.88e-05	0.000548	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CD—malignant glioma	1.84e-05	0.000535	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.84e-05	0.000535	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.8e-05	0.000525	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTT1—malignant glioma	1.79e-05	0.000521	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NCOR1—malignant glioma	1.78e-05	0.000517	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN2B—malignant glioma	1.78e-05	0.000517	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HES1—malignant glioma	1.69e-05	0.000493	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NCOR1—malignant glioma	1.69e-05	0.00049	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTGS1—malignant glioma	1.68e-05	0.000489	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.67e-05	0.000487	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—RAF1—malignant glioma	1.64e-05	0.000477	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PDGFRA—malignant glioma	1.61e-05	0.000469	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CB—malignant glioma	1.6e-05	0.000466	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—BCHE—malignant glioma	1.56e-05	0.000454	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.56e-05	0.000453	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1.55e-05	0.00045	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC5A5—malignant glioma	1.54e-05	0.000449	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTP1—malignant glioma	1.54e-05	0.000447	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CAT—malignant glioma	1.49e-05	0.000435	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TERT—malignant glioma	1.49e-05	0.000432	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HLA-A—malignant glioma	1.49e-05	0.000432	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IL2—malignant glioma	1.47e-05	0.000428	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.46e-05	0.000424	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PDGFB—malignant glioma	1.45e-05	0.000422	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CAV1—malignant glioma	1.45e-05	0.000422	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.45e-05	0.00042	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGFR1—malignant glioma	1.44e-05	0.00042	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	1.42e-05	0.000413	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HIF1A—malignant glioma	1.42e-05	0.000413	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NCOR1—malignant glioma	1.41e-05	0.000411	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.38e-05	0.000403	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CAV1—malignant glioma	1.37e-05	0.0004	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CG—malignant glioma	1.32e-05	0.000384	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—BAD—malignant glioma	1.29e-05	0.000376	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOTCH1—malignant glioma	1.28e-05	0.000372	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PPARG—malignant glioma	1.27e-05	0.000371	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.26e-05	0.000367	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD80—malignant glioma	1.25e-05	0.000365	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—APC—malignant glioma	1.25e-05	0.000364	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—VEGFA—malignant glioma	1.25e-05	0.000364	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTP1—malignant glioma	1.24e-05	0.000361	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EGF—malignant glioma	1.24e-05	0.00036	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PTPN11—malignant glioma	1.23e-05	0.000358	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CAT—malignant glioma	1.21e-05	0.000352	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—BRAF—malignant glioma	1.18e-05	0.000342	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CD—malignant glioma	1.16e-05	0.000338	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CAV1—malignant glioma	1.15e-05	0.000335	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKT2—malignant glioma	1.14e-05	0.000333	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NCOR1—malignant glioma	1.14e-05	0.000332	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CD—malignant glioma	1.1e-05	0.00032	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.1e-05	0.00032	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—KRAS—malignant glioma	1.06e-05	0.000309	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGF2—malignant glioma	1.05e-05	0.000306	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CG—malignant glioma	1.05e-05	0.000305	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CB—malignant glioma	1.01e-05	0.000294	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PPARG—malignant glioma	1.01e-05	0.000294	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTGS2—malignant glioma	1e-05	0.000292	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MDM2—malignant glioma	9.85e-06	0.000287	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—RAF1—malignant glioma	9.82e-06	0.000286	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CA—malignant glioma	9.77e-06	0.000284	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ERBB2—malignant glioma	9.71e-06	0.000283	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CB—malignant glioma	9.59e-06	0.000279	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TP53—malignant glioma	9.45e-06	0.000275	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CAV1—malignant glioma	9.31e-06	0.000271	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CD—malignant glioma	9.21e-06	0.000268	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.89e-06	0.000259	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTEN—malignant glioma	8.74e-06	0.000254	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CG—malignant glioma	8.48e-06	0.000247	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PTEN—malignant glioma	8.28e-06	0.000241	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PPARG—malignant glioma	8.18e-06	0.000238	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CB—malignant glioma	8.03e-06	0.000234	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—AKT1—malignant glioma	7.98e-06	0.000232	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CD—malignant glioma	7.45e-06	0.000217	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—STAT3—malignant glioma	7.41e-06	0.000216	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PTEN—malignant glioma	6.94e-06	0.000202	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MYC—malignant glioma	6.88e-06	0.0002	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EGFR—malignant glioma	6.73e-06	0.000196	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CB—malignant glioma	6.5e-06	0.000189	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTGS2—malignant glioma	6.44e-06	0.000187	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KRAS—malignant glioma	6.36e-06	0.000185	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CA—malignant glioma	6.17e-06	0.000179	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CA—malignant glioma	5.84e-06	0.00017	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTEN—malignant glioma	5.61e-06	0.000163	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—AKT1—malignant glioma	5.04e-06	0.000147	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CA—malignant glioma	4.89e-06	0.000142	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKT1—malignant glioma	4.77e-06	0.000139	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AKT1—malignant glioma	4e-06	0.000116	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CA—malignant glioma	3.96e-06	0.000115	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AKT1—malignant glioma	3.23e-06	9.41e-05	CbGpPWpGaD
